Nebulizers Market Analysis

Based on portability, the nebulizers market from the tabletop segment is projected to be worth more than USD 1 billion by 2032. The availability of advantageous reimbursement policies in various countries, as well as the operational benefits afforded by these devices, are set to facilitate segment progress. Tabletop nebulizers are highly preferred for young children who routinely receive treatments since they come in fun designs and are also available with activity boards that help keep children occupied during their treatments.
 

Nebulizers market is classified based on end-use into medical and homecare. The homecare segment is set to witness lucrative growth at over 9.5% CAGR through 2032 owing to the rising popularity of homecare nebulizer equipment as well as the expanding geriatric population base suffering from respiratory ailments. Additionally, the widespread availability of innovative and compact nebulizers integrated with new technologies that minimize their noise and enhance their functionality makes them ideal for use at home. This has increased their uptake in home healthcare, which is anticipated to bolster segment development.
 

North America nebulizers market accounted for over 38% of the overall industry revenue in 2022. The regional industry is poised to exhibit robust growth between 2023 and 2032 resulting from the high cases of respiratory disorders and chronic diseases. Around 9 million Americans are diagnosed with COPD, however, this figure might be significantly higher as over 18 million persons have indications of impaired lung function that could indicate undiagnosed COPD. Major government and healthcare organizations, including the American Lung Association, are working on reducing the burden of lung diseases and lung cancer through education and support programs for patients, which is expected to raise the demand for nebulizers for treatment.